Strand's study looks for biomarkers and SNPs:
This article was originally published in Clinica
Executive Summary
Indian bioinformatic company, Strand Genomics, is to conduct clinical trials to identify disease-specific biomarkers and single nucleotide polymorphisms (SNPs). The Bangalore-based firm says that it will collaborate with its partners who have US-certified data-generation facilities to produce disease-specific clinical data.